valproic acid has been researched along with Fukuhara Disease in 2 studies
Valproic Acid: A fatty acid with anticonvulsant and anti-manic properties that is used in the treatment of EPILEPSY and BIPOLAR DISORDER. The mechanisms of its therapeutic actions are not well understood. It may act by increasing GAMMA-AMINOBUTYRIC ACID levels in the brain or by altering the properties of VOLTAGE-GATED SODIUM CHANNELS.
valproic acid : A branched-chain saturated fatty acid that comprises of a propyl substituent on a pentanoic acid stem.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Levetiracetam (LEV) treatment was started in combination with VPA in a patient with typical clinical, histological, and biochemical features of MERRF due to a mutation on the tRNA of Phenilalanine gene." | 1.33 | Antimyoclonic effect of levetiracetam in MERRF syndrome. ( Filosto, M; Galli, R; Mancuso, M; Murri, L; Pizzanelli, C; Siciliano, G, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mancuso, M | 1 |
| Galli, R | 1 |
| Pizzanelli, C | 1 |
| Filosto, M | 1 |
| Siciliano, G | 1 |
| Murri, L | 1 |
| Rasmussen, M | 1 |
| Sanengen, T | 1 |
| Skullerud, K | 1 |
| Kvittingen, EA | 1 |
| Skjeldal, OH | 1 |
2 other studies available for valproic acid and Fukuhara Disease
| Article | Year |
|---|---|
Antimyoclonic effect of levetiracetam in MERRF syndrome.
Topics: Activities of Daily Living; Anticonvulsants; Atrophy; Brain; Drug Therapy, Combination; Female; Gene | 2006 |
Evidence that Alpers-Huttenlocher syndrome could be a mitochondrial disease.
Topics: Cerebral Cortex; Child; Child, Preschool; Diffuse Cerebral Sclerosis of Schilder; Epilepsy, Absence; | 2000 |